Bio Path Holdings Inc (BPTH)

[SJSTOCKSHARK]

While it is good enrollment is on track for the combined study I do wish the company was more specific on when the results would be announced. The second half of the year could mean December 31, 2015.

It is nice that the CEO/CFO/COB is traveling to San Diego to give a speech about our technology. Certainly getting the word out on this company is positive. However, I would have appreciated more substantial news like the efficacy of the combined trial is showing good results to date, we have a new partner who will utilize our delivery and pay us royalties, we have a new independent board member, we have a new partner for our present drugs, we have a new IR firm, we have a new major investor who has provided us with substantial funds in a private placement, we have a new partner who will pay for one of our drugs to complete the FDA trials, we have a new partner to market our drug if the combined trial is successful, we are expanding our trials into breast cancer or solid tumor drugs, we have added additional drugs to our pipeline, we have merged or been bought out at an exorbitant price etc. etc.